146 related articles for article (PubMed ID: 10434045)
1. Structural features and anticoagulant activities of a novel natural low molecular weight heparin from the shrimp Penaeus brasiliensis.
Dietrich CP; Paiva JF; Castro RA; Chavante SF; Jeske W; Fareed J; Gorin PA; Mendes A; Nader HB
Biochim Biophys Acta; 1999 Aug; 1428(2-3):273-83. PubMed ID: 10434045
[TBL] [Abstract][Full Text] [Related]
2. New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin.
Nader HB; Kobayashi EY; Chavante SF; Tersariol IL; Castro RA; Shinjo SK; Naggi A; Torri G; Casu B; Dietrich CP
Glycoconj J; 1999 Jun; 16(6):265-70. PubMed ID: 10579695
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulant and antiprotease effects of a novel heparinlike compound from shrimp (Penaeus brasiliensis) and its neutralization by heparinase I.
Demir M; Iqbal O; Dietrich CP; Hoppensteadt DA; Ahmad S; Daud AN; Fareed J
Clin Appl Thromb Hemost; 2001 Jan; 7(1):44-52. PubMed ID: 11190904
[TBL] [Abstract][Full Text] [Related]
4. A novel heparan sulphate with high degree of N-sulphation and high heparin cofactor-II activity from the brine shrimp Artemia franciscana.
Chavante SF; Santos EA; Oliveira FW; Guerrini M; Torri G; Casu B; Dietrich CP; Nader HB
Int J Biol Macromol; 2000 Mar; 27(1):49-57. PubMed ID: 10704986
[TBL] [Abstract][Full Text] [Related]
5. A heparin-like glycosaminoglycan from shrimp containing high levels of 3-O-sulfated D-glucosamine groups in an unusual trisaccharide sequence.
Chavante SF; Brito AS; Lima M; Yates E; Nader H; Guerrini M; Torri G; Bisio A
Carbohydr Res; 2014 May; 390():59-66. PubMed ID: 24708994
[TBL] [Abstract][Full Text] [Related]
6. Isolation of a pure octadecasaccharide with antithrombin activity from an ultra-low-molecular-weight heparin.
Mourier PA; Guichard OY; Herman F; Viskov C
Anal Biochem; 2014 May; 453():7-15. PubMed ID: 24561026
[TBL] [Abstract][Full Text] [Related]
7. Controllable production of low molecular weight heparins by combinations of heparinase I/II/III.
Wu J; Zhang C; Mei X; Li Y; Xing XH
Carbohydr Polym; 2014 Jan; 101():484-92. PubMed ID: 24299802
[TBL] [Abstract][Full Text] [Related]
8. Fractionation and structural features of two heparin families with high antithrombotic, antilipemic and anticoagulant activities.
Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP; Casu B; Torri G
Arzneimittelforschung; 1985; 35(8):1215-9. PubMed ID: 4074437
[TBL] [Abstract][Full Text] [Related]
9. Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy.
Nader HB; Porcionatto MA; Tersariol IL; Pinhal MA; Oliveira FW; Moraes CT; Dietrich CP
J Biol Chem; 1990 Oct; 265(28):16807-13. PubMed ID: 2211596
[TBL] [Abstract][Full Text] [Related]
10. A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential.
Brito AS; Cavalcante RS; Palhares LC; Hughes AJ; Andrade GP; Yates EA; Nader HB; Lima MA; Chavante SF
Carbohydr Polym; 2014 Jan; 99():372-8. PubMed ID: 24274520
[TBL] [Abstract][Full Text] [Related]
11. Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.
Alekseeva A; Casu B; Cassinelli G; Guerrini M; Torri G; Naggi A
Anal Bioanal Chem; 2014 Jan; 406(1):249-65. PubMed ID: 24253408
[TBL] [Abstract][Full Text] [Related]
12. Heparinase II from Flavobacterium heparinum. Action on chemically modified heparins.
Moffat CF; McLean MW; Long WF; Williamson FB
Eur J Biochem; 1991 Apr; 197(2):449-59. PubMed ID: 2026167
[TBL] [Abstract][Full Text] [Related]
13. Chemical change involved in the oxidative-reductive depolymerization of heparin.
Nagasawa K; Uchiyama H; Sato N; Hatano A
Carbohydr Res; 1992 Dec; 236():165-80. PubMed ID: 1337863
[TBL] [Abstract][Full Text] [Related]
14. The uronic acid composition of anticoagulantly active and inactive heparin.
Rosenfeld L; Radoff S; Danishefsky I
Arch Biochem Biophys; 1985 Nov; 242(2):574-8. PubMed ID: 4062296
[TBL] [Abstract][Full Text] [Related]
15. Differential anticoagulant activity of heparin fragments prepared using microbial heparinase.
Linhardt RJ; Grant A; Cooney CL; Langer R
J Biol Chem; 1982 Jul; 257(13):7310-3. PubMed ID: 7085627
[TBL] [Abstract][Full Text] [Related]
16. Heparins and heparinoids: occurrence, structure and mechanism of antithrombotic and hemorrhagic activities.
Nader HB; Lopes CC; Rocha HA; Santos EA; Dietrich CP
Curr Pharm Des; 2004; 10(9):951-66. PubMed ID: 15078126
[TBL] [Abstract][Full Text] [Related]
17. Distribution of sulfated glycosaminoglycans in the animal kingdom: widespread occurrence of heparin-like compounds in invertebrates.
Medeiros GF; Mendes A; Castro RA; Baú EC; Nader HB; Dietrich CP
Biochim Biophys Acta; 2000 Jul; 1475(3):287-94. PubMed ID: 10913828
[TBL] [Abstract][Full Text] [Related]
18. Heparin in molluscs: chemical, enzymatic degradation and 13C and 1H n.m.r. spectroscopical evidence for the maintenance of the structure through evolution.
Dietrich CP; Nader HB; de Paiva JF; Santos EA; Holme KR; Perlin AS
Int J Biol Macromol; 1989 Dec; 11(6):361-6. PubMed ID: 2489105
[TBL] [Abstract][Full Text] [Related]
19. Distribution of glucuronic and iduronic acid units in heparin chains.
Radoff S; Danishefsky I
J Biol Chem; 1985 Dec; 260(28):15106-11. PubMed ID: 4066664
[TBL] [Abstract][Full Text] [Related]
20. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
